Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and biologic cancer therapeutics, announced that CEO Masoud Tavazoie, M.D., Ph.D., will participate in multiple virtual healthcare investor conferences taking place during the month of March.
March 8, 2022
· 2 min read